Login / Signup

Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial.

U KiltzA MoltoC Lopez-MedinaM DougadosD van der HeijdeA BoonenF Van den BoschJ Braun
Published in: Seminars in arthritis and rheumatism (2024)
The data-driven thresholds of the ASAS HI identified in a longitudinal observational setting perform well in the context of a randomized trial.
Keyphrases
  • healthcare
  • public health
  • clinical trial
  • mental health
  • phase ii
  • randomized controlled trial
  • cross sectional
  • rheumatoid arthritis
  • combination therapy
  • human health
  • replacement therapy
  • double blind